Jinhua Central Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Jinhua China (1910)

Organization Overview

First Clinical Trial
2015
NCT02442440
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Jinhua Central Hospital | Jinhua Municipal Central Hospital | Jinhua Municipal Central Hospital Medical Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenomyosis (Phase 3)

Anemia (Phase 4)

Anemia, Aplastic (Phase 4)

Breast Neoplasms (Phase 4)

Carcinoma (Phase 3)

Hypertriglyceridemia (Phase 4)

Nasopharyngeal Carcinoma (Phase 3)

Pancreatitis (Phase 4)

Pneumonia (Phase 4)

Shock (Phase 2)

Shock, Septic (Phase 2)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 29